October 11-14, 2022
Visit us in booth 79 at World Vaccine Congress Europe to learn what it means to be INSIDE AFRICA – experience the tastes, smells and sounds of sub-Saharan Africa and meet with our team members to discuss how your clinical trials would benefit from our experience on the African continent.
Webinar: Africa’s Potential for Clinical Research: Population Diversity, Expanding Therapeutic Area Expertise and Long-Standing Stakeholder Engagement
Missed the webinar? View the recording to hear about Africa’s strong clinical research foundation, based on collaborative approaches with numerous stakeholders, complex studies with long-term follow-up and a community-centered approach to fostering enrollment and retention.
April 18-21, 2022
Attending the World Vaccine Congress 2022? Stop by our booth for a presentation about COVID-19 vaccine development, conducting trials in sub-Saharan Africa or using novel methods to ensure equitable access to clinical research. Members of our team will also be available to talk about our capabilities and services.
April 19, 2022
Join this roundtable, hosted by FHI Clinical, to discuss and compare experiences with COVID-19 and how those might be relevant when designing trials for other indications.
April 12, 2022
Join us for an episode of Careers in Pharma, a webinar featuring Daniel Joffe, Senior Clinical Project Manager at FHI Clinical, as he talks about his role as a project manager, challenges he faces and skills he uses.
February 22, 2022
Join us for this plenary discussion in which experts in infectious diseases discuss how real-world epidemiology data, site capacity data and biosurveillance methodology could help identify TB-prevalent populations during protocol design, helping to ensure an adequate sample for TB vaccine development.
February 7-10, 2022
Attending SCOPE? Learn more about how we ensure best-fit sites with the most appropriate capabilities and patient populations tailored to your study protocol. Contact us to set aside time to review your feasibility and study start-up needs.